Verition Fund Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-17,500
Closed -$161K – 3521
2024
Q3
$161K Hold
17,500
– – ﹤0.01% 2932
2024
Q2
$171K Buy
+17,500
New +$213K ﹤0.01% 2642
2021
Q3
– Sell
-185,000
Closed -$30.8M – 2297
2021
Q2
$30.8M Sell
185,000
-15,000
-8% -$2.43M 0.28% 55
2021
Q1
$36.4M Buy
+200,000
New +$46.4M 0.41% 30

Other funds holding TDOC

Verition Fund Management's TDOC Position: Q2 2026 in Review

Verition Fund Management sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 35,379 shares — an estimated $193K sold.

Verition Fund Management first reported a position in TDOC in Q2 2019 and held it in 19 quarters. The position peaked at $2.53M in Q3 2019. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Verition Fund Management reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 35,379 Teladoc Health shares in Q2 2026, an estimated $193K.
  • Verition Fund Management first reported a position in Teladoc Health in Q2 2019 and held it in 19 quarters.
  • Verition Fund Management's Teladoc Health position peaked at $2.53M in Q3 2019.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.